White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Neuropeptide Y Gene Polymorphisms Confer Risk of Early-Onset Atherosclerosis

Shah, S.H., Freedman, N.J., Zhang, L., Crosslin, D.R., Stone, D.H., Haynes, C., Johnson, J., Nelson, S., Wang, L., Connelly, J.J., Muehlbauer, M., Ginsburg, G.S., Crossman, D.C., Jones, C.J.H., Vance, J., Sketch, M.H., Granger, C.B., Newgard, C.B., Gregory, S.G., Goldschmidt-Clermont, P.J., Kraus, W.E., Hauser, E.R. and Cox, G.A. (2009) Neuropeptide Y Gene Polymorphisms Confer Risk of Early-Onset Atherosclerosis. PLoS Genetics, 5 (1). e1000318. ISSN 1553-7404

Full text available as:

Abstract

Neuropeptide Y (NPY) is a strong candidate gene for coronary artery disease (CAD). We have previously identified genetic linkage to familial CAD in the genomic region of NPY. We performed follow-up genetic, biostatistical, and functional analysis of NPY in early-onset CAD. In familial CAD (GENECARD, N = 420 families), we found increased microsatellite linkage to chromosome 7p14 (OSA LOD = 4.2, p = 0.004) in 97 earliest age-of-onset families. Tagged NPY SNPs demonstrated linkage to CAD of a 6-SNP block (LOD = 1.58–2.72), family-based association of this block with CAD (p = 0.02), and stronger linkage to CAD in the earliest age-of-onset families. Association of this 6-SNP block with CAD was validated in: (a) 556 non-familial early-onset CAD cases and 256 controls (OR 1.46–1.65, p = 0.01–0.05), showing stronger association in youngest cases (OR 1.84–2.20, p = 0.0004–0.09); and (b) GENECARD probands versus non-familial controls (OR 1.79–2.06, p = 0.003–0.02). A promoter SNP (rs16147) within this 6-SNP block was associated with higher plasma NPY levels (p = 0.04). To assess a causal role of NPY in atherosclerosis, we applied the NPY1-receptor–antagonist BIBP-3226 adventitially to endothelium-denuded carotid arteries of apolipoprotein E-deficient mice; treatment reduced atherosclerotic neointimal area by 50% (p = 0.03). Thus, NPY variants associate with atherosclerosis in two independent datasets (with strong age-of-onset effects) and show allele-specific expression with NPY levels, while NPY receptor antagonism reduces atherosclerosis in mice. We conclude that NPY contributes to atherosclerosis pathogenesis.

Item Type: Article
Copyright, Publisher and Additional Information: © 2009 Shah et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield)
Depositing User: Sheffield Import
Date Deposited: 30 Oct 2009 15:02
Last Modified: 15 Sep 2014 04:09
Published Version: http://dx.doi.org/10.1371/journal.pgen.1000318
Status: Published
Publisher: Public Library of Science
Identification Number: 10.1371/journal.pgen.1000318
URI: http://eprints.whiterose.ac.uk/id/eprint/10024

Actions (repository staff only: login required)